Mathematical Evidence That Quantum Entropy Shapes Drug Discovery By Mansour Ansari, QuantumCURE Pro™ | Oklahoma Quantum Entropy Validation: ABL1 Drug Discovery Benchmark By Mansour Ansari, QuantumCURE Pro™ | Oklahoma City Over the past year, I’ve spent well over 3,500 hours  building and testing a quantum-enhanced drug discovery system. To find out if it actually works, and whether quantum entropy really leaves a measurable signature, I ran a rigorous validation on ABL1 (Abel

So, I have created a nifty molecular docking engine that can stand shoulder-to-shoulder with big-pharma platforms that cost $100K per year per license. Ok, I admit I don’t have the pedigree of a 20-year vendor track record, and I’m not a biologist, but I am  very good at building complex systems and making them actually run in the real world. For the past 30 years, I’ve shipped and operated mission-critical software for video, networking, and now quantum-enhanced simulation.

I didn’t plan to turn my life into a comic book at 70… but here we are. Over the past year I’ve been buried in code, quantum entropy, and molecular docking—building QuantumCURE Pro, my “one-man drug discovery factory.” Somewhere between late-night bug fixes and IC₅₀ curves, I thought: I’ve lived a weird arc from wiring TV stations for live tornado coverage, to chasing storms in a yellow Hummer, to now chasing cancer cells on a laptop. That’s a story. So I decided to tell it v